Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predicting mucosal inflammation in IBD patients using patient-reported symptom scores and a faecal calprotectin home test: protocol for a multicentre prospective validation study.
Janssen L, van Linschoten RCA, West RL, Gilissen LPL, Romberg-Camps M, Brandts L, Mujagic Z, Römkens TE, Pierik M. Janssen L, et al. Among authors: van linschoten rca. BMJ Open. 2024 Oct 7;14(10):e076290. doi: 10.1136/bmjopen-2023-076290. BMJ Open. 2024. PMID: 39375184 Free PMC article.
Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents.
van Linschoten RCA, Visser E, Niehot CD, van der Woude CJ, Hazelzet JA, van Noord D, West RL. van Linschoten RCA, et al. Among authors: van der woude cj, van noord d. Aliment Pharmacol Ther. 2021 Aug;54(3):234-248. doi: 10.1111/apt.16445. Epub 2021 Jun 11. Aliment Pharmacol Ther. 2021. PMID: 34114667 Free PMC article. Review.
Value-based care pathway for inflammatory bowel disease: a protocol for the multicentre longitudinal non-randomised parallel cluster IBD Value study with baseline period.
van Linschoten RCA, van Leeuwen N, Nieboer D, Birnie E, Scherpenzeel M, Verweij KE, de Jonge V, Hazelzet JA, van der Woude CJ, West RL, van Noord D; Southwest Netherlands IBD Study Group. van Linschoten RCA, et al. BMJ Open. 2022 Jan 12;12(1):e050539. doi: 10.1136/bmjopen-2021-050539. BMJ Open. 2022. PMID: 35022169 Free PMC article. Clinical Trial.
Variation Between Hospitals in Outcomes and Costs of IBD Care: Results From the IBD Value Study.
van Linschoten RCA, van der Woude CJ, Visser E, van Leeuwen N, Bodelier AGL, Fitzpatrick C, de Jonge V, Vermeulen H, Verweij KE, van der Wiel S, Nieboer D, Birnie E, van der Horst D, Hazelzet JA, van Noord D, West RL. van Linschoten RCA, et al. Inflamm Bowel Dis. 2024 Apr 26:izae095. doi: 10.1093/ibd/izae095. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 38666643
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
van Linschoten RCA, Jansen FM, Pauwels RWM, Smits LJT, Atsma F, Kievit W, de Jong DJ, de Vries AC, Boekema PJ, West RL, Bodelier AGL, Gisbertz IAM, Wolfhagen FHJ, Römkens TEH, Lutgens MWMD, van Bodegraven AA, Oldenburg B, Pierik MJ, Russel MGVM, de Boer NK, Mallant-Hent RC, Ter Borg PCJ, van der Meulen-de Jong AE, Jansen JM, Jansen SV, Tan ACITL, van der Woude CJ, Hoentjen F; LADI study group, the Dutch Initiative on Crohn, Colitis (ICC). van Linschoten RCA, et al. Dig Dis Sci. 2024 Jun;69(6):2165-2174. doi: 10.1007/s10620-024-08410-z. Epub 2024 Apr 9. Dig Dis Sci. 2024. PMID: 38594435 Free PMC article. Clinical Trial.
Handling missing values in the analysis of between-hospital differences in ordinal and dichotomous outcomes: a simulation study.
van Linschoten RCA, Amini M, van Leeuwen N, Eijkenaar F, den Hartog SJ, Nederkoorn PJ, Hofmeijer J, Emmer BJ, Postma AA, van Zwam W, Roozenbeek B, Dippel D, Lingsma HF; MR CLEAN Registry Investigators. van Linschoten RCA, et al. BMJ Qual Saf. 2023 Dec;32(12):742-749. doi: 10.1136/bmjqs-2023-016387. Epub 2023 Sep 21. BMJ Qual Saf. 2023. PMID: 37734955 Clinical Trial.
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial.
Jansen FM, van Linschoten RCA, Kievit W, Smits LJT, Pauwels RWM, de Jong DJ, de Vries AC, Boekema PJ, West RL, Bodelier AGL, Gisbertz IAM, Wolfhagen FHJ, Römkens TEH, Lutgens MWMD, van Bodegraven AA, Oldenburg B, Pierik MJ, Russel MGVM, de Boer NK, Mallant-Hent RC, Ter Borg PCJ, van der Meulen-de Jong AE, Jansen JM, Jansen SV, Tan ACITL, Hoentjen F, van der Woude CJ; LADI study group. Jansen FM, et al. Among authors: van linschoten rca. J Crohns Colitis. 2023 Nov 24;17(11):1771-1780. doi: 10.1093/ecco-jcc/jjad101. J Crohns Colitis. 2023. PMID: 37310877 Free PMC article. Clinical Trial.
Dutch normative data of the sexual distress scale and the body image scale.
Huberts AS, Peeters NJMCV, Kaplan ZLR, van Linschoten RCA, Pastoor H, van der Woude CJ, Koppert LB. Huberts AS, et al. Among authors: van linschoten rca. Qual Life Res. 2023 Oct;32(10):2829-2837. doi: 10.1007/s11136-023-03434-w. Epub 2023 May 16. Qual Life Res. 2023. PMID: 37193810 Free PMC article.
14 results